Investigational agent single ascending dose safety, tolerability, and PK study. September 3, 2024 to march 2, 2026. N01DA-23-8935
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Altasciences Clinical Kansas Inc. UEI WZ5RGEMMQ3W9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,724,199
Award facts
- Contract value 100% obligated
- $1,724,198.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Shawnee Mission, KS 66212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $287,423 | |
| Original award | $1,436,776 |
About this award
This is a firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO) located in Overland Park, Kansas. The contract is for a study to evaluate the safety, tolerability, and pharmacokinetics of an investigational agent. The period of performance is from September 3, 2024, to March 11, 2026, with a ceiling value of $1,724,198.59. The contract was not set aside for any specific business size or socioeconomic category. Altasciences Clinical Kansas Inc. holds a larger $21 million single-award indefinite delivery contract with NIDA for conducting various pharmacokinetic and pharmacodynamic trials to support medication development for substance use disorders.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Altasciences Clinical Kansas Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 12, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $1,724,199 on 75N95024F00001.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95023D00019, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award